A second international co-operative investigation into thiacetazone side-effects. Rashes on two thiacetazone containing regimens.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000462:Algeria; D003604:Czechoslovakia; D003888:Desensitization, Immunologic; D003875:Drug Eruptions / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D005002:Ethiopia; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007194:India; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects; D008296:Malaysia; D009018:Morocco; D010154:Pakistan; D012846:Singapore; D013307:Streptomycin / Q000008:administration & dosage / Q000009:adverse effects; D013828:Thioacetazone / Q000008:administration & dosage / Q000009:adverse effects*; D014300:Trinidad and Tobago
D000305:Adrenal Cortex Hormones; D006634:Histamine H1 Antagonists; D013828:Thioacetazone; D007538:Isoniazid; D013307:Streptomycin